NasdaqGM:KODBiotechs
Kodiak Sciences Faces Going Concern Warning As Valuation Gap Persists
Kodiak Sciences (NasdaqGM:KOD) auditor has raised substantial doubt about the company’s ability to continue as a going concern.
The warning comes shortly after Kodiak reported successful Phase 3 GLOW2 results for Zenkuda and outlined plans for a Biologics License Application.
Kodiak has filed a shelf registration, giving the company the option to raise additional capital in the future.
Kodiak Sciences, a clinical stage biopharma company focused on retinal disease, is now in a situation...